ReAble to Acquire IOMED for $22 Million
ReAble, a privately held rehabilitation and orthopedic device company based on Austin, TX, announced today that it would acquire drug-delivery firm IOMED for $22 million […]
Blog
Neurotech Investments on the Rise
Venture capitalists pumped nearly $1.7 billion into neurotechnology in 2006, according to a report released today that paints the field as a frontier industry on […]
CoreValve Out in Front with Non-Invasive Heart Valve
CoreValve received CE Mark approval yesterday for its non-invasive heart valve, putting the Irvine, CA, company out in front of other startups working on similar technologies. The company’s ReValving System […]
Robotic Devices Move Into the Mainstream…and Beyond
Cardiogenesis, an Irvine, CA-based medical device company that specializes in devices that stimulate cardiac angiogenesis, submitted a PMA last week for its minimally invasive Robotic 5.0 […]
Amedica Secures $13.2 Million in Series D Financing
Amedica, a Salt Lake City, UT, company that makes orthopedic implants, today announced that it has raised $13.2 million in Series D financing. Including this round, for […]
Teknimed Inks Deal with Smith & Nephew
Teknimed, a privately held French company that makes biomaterials for bone surgery, has signed a deal to allow Smith & Nephew to market its FDA-approved […]
CEO Says Private Placement Forgives ‘Hiccups’
Bruce Kehr, CEO of Rockville, MD-based InforMedix, thinks private placement funding is worth the wait. The neuropsychiatrist turned CEO recently explained to the Washington Business […]
BlueSky May Make $110 Million off Smith & Nephew Deal
The two founders of BlueSky Medical Group, a private med tech company based in Carlsbad, CA, stand to make up to $110 million off a deal […]
Schwarz Out in Front with Parkinson’s Patch
Schwarz Pharma today received FDA approval for Neupro, its transdermal patch for treatment of early-stage Parkinson’s disease. Neupro has been on the market in Europe […]
‘Banner Day’ of Funding for Life Sciences Startups
Yesterday, according to Red Herring, was “a banner day for life sciences companies searching for money,” with companies from the U.S., Canada, Germany and India announcing […]